Abstract
Purpose
Oxidation is one of the most common degradation pathways for active pharmaceutical ingredients (APIs) in pharmaceutical formulations, mostly involving 1-electron processes via peroxy radicals and 2-electron processes by peroxides. In liquid pharmaceutical formulations, several factors can impact oxidative instabilities including pH, excipient impurities, headspace oxygen, and the potential for photo-oxidation. Photo-oxidation can be particularly challenging to characterize given the number of oxidative mechanisms which can occur. This was observed during formulation development of a new chemical entity, MK-1454, where a degradation peak was observed during photostability studies which was not previously observed during peroxide and peroxyradical forced stress studies.
Methods
To gain a fundamental understanding of reactive oxygen species generation and its role in degradation of MK-1454, experiments were performed with materials which either generate or measure reactive oxygen species including organic hydroperoxides, singlet oxygen, and superoxide to fundamentally understand a photodegradation mechanism which was observed in the original formulation. LC-MS experiments further elucidated the structure and mechanism of this observed degradation pathway.
Results
A clear relationship between the decrease in dissolved oxygen after light exposure and the loss of MK-1454 was established. The data indicate that singlet oxygen is the most likely contributor of a particular photodegradation product. The singlet oxygen was generated by the inactive ingredients in the formulation, and LC-MS confirm this as the most likely pathway.
Conclusion
This work highlights the importance of understanding photochemical degradation of APIs in solution formulations and provides approaches which can better elucidate those mechanisms and thereby control strategies.
Similar content being viewed by others
Data Availability
The datasets generated or analzyed during the current study are not publicly available due to the novel drug, MK-1454, and its formulations being the intellectual property of Merck & Co., Inc., Rahway, NJ, USA but are available from the corresponding author in reasonable request.
References
Akers MJ. Excipient–drug interactions in parenteral formulations. J Pharm Sci. 2002;91(11):2283–300.
Stroop SD, Conca DM, Lundgard RP, Renz ME, Peabody LM, Leigh SD. Photosensitizers form in histidine buffer and mediate the photodegradation of a monoclonal antibody. J Pharm Sci. 2011;100(12):5142–55.
Wang C, Yamniuk A, Dai J, Chen S, Stetsko P, Ditto N, et al. Investigation of a degradant in a biologics formulation buffer containing L-histidine. Pharm Res. 2015;32(8):2625–35.
Hovorka SW, Schöneich C. Oxidative degradation of pharmaceuticals: theory, mechanisms and inhibition. J Pharm Sci. 2001;90(3):253–69.
Janga KY, King T, Ji N, Sarabu S, Shadambikar G, Sawant S, et al. Photostability issues in pharmaceutical dosage forms and photostabilization. AAPS PharmSciTech. 2018;19(1):48–59.
Kerwin BA, Remmele RL Jr. Protect from light: photodegradation and protein biologics. J Pharm Sci. 2007;96(6):1468–79.
Li S, Schöneich C, Borchardt RT. Chemical instability of protein pharmaceuticals: mechanisms of oxidation and strategies for stabilization. Biotechnol Bioeng. 1995;48(5):490–500.
Di Mascio P, Martinez GR, Miyamoto S, Ronsein GE, Medeiros MH, Cadet J. Singlet molecular oxygen reactions with nucleic acids, lipids, and proteins. Chem Rev. 2019;119(3):2043–86.
Davies MJ. Singlet oxygen-mediated damage to proteins and its consequences. Biochem Biophys Res Commun. 2003;305(3):761–70.
Davies MJ, Truscott RJ. Photo-oxidation of proteins and its role in cataractogenesis. J Photochem Photobiol B Biol. 2001;63(1–3):114–25.
Igarashi N, Onoue S, Tsuda Y. Photoreactivity of amino acids: tryptophan-induced photochemical events via reactive oxygen species generation. Anal Sci. 2007;23(8):943–8.
Foote CS. Photosensitized oxygenations and the role of singlet oxygen. Acc Chem Res. 1968;1(4):104–10.
Foote CS. Definition of type I and type II photosensitized oxidation. Photochem Photobiol. 1991;54(5):659.
Baptista MS, Cadet J, Di Mascio P, Ghogare AA, Greer A, Hamblin MR, et al. Type I and Type II photosensitized oxidation reactions: guidelines and mechanistic pathways. Photochem Photobiol. 2017;93(4):912–9.
DeRosa MC, Crutchley RJ. Photosensitized singlet oxygen and its applications. Coord Chem Rev. 2002;233:351–71.
Haag WR, Gassman E. Singlet oxygen in surface waters—Part I: Furfuryl alcohol as a trapping agent. Chemosphere. 1984;13(5–6):631–40.
Wang MJ, Xiang XY, Zuo YG, Peng JB, Lu K, Dempsey C, et al. Singlet oxygen production abilities of oxidated aromatic compounds in natural water. Chemosphere. 2020;258.
Razavi B, Ben Abdelmelek S, Song WH, O'Shea KE, Cooper WJ. Photochemical fate of atorvastatin (lipitor) in simulated natural waters. Water Res. 2011;45(2):625–31.
Leach AG, Houk KN. Diels-Alder and ene reactions of singlet oxygen, nitroso compounds and triazolinediones: transition states and mechanisms from contemporary theory. Chem Commun. 2002;12:1243–55.
Batakliev T, Georgiev V, Anachkov M, Rakovsky S, Zaikov GE. Ozone decomposition. Interdiscip Toxicol. 2014;7(2):47–59.
Alsheyab MAT, Munoz AH. Optimisation of ozone production for water and wastewater treatment. Desalination. 2007;217(1–3):1–7.
Yamashita K, Miyoshi T, Arai T, Endo N, Itoh H, Makino K, et al. Ozone production by amino acids contributes to killing of bacteria. Proc Natl Acad Sci. 2008;105(44):16912–7.
Skrotzki EA, Vandavasi JK, Newman SG. Ozone-mediated amine oxidation and beyond: a solvent-free, flow-chemistry approach. J Org Chem. 2021;86(20):14169–76.
Pospíšil P, Prasad A, Rác M. Mechanism of the formation of electronically excited species by oxidative metabolic processes: role of reactive oxygen species. Biomolecules. 2019;9(7):258.
Ozawa T, Hanaki A. Reactions of superoxide with water and with hydrogen peroxide. Chem Pharm Bull. 1981;29(4):926–8.
Onoue S, Hosoi K, Wakuri S, Iwase Y, Yamamoto T, Matsuoka N, et al. Establishment and intra−/inter-laboratory validation of a standard protocol of reactive oxygen species assay for chemical photosafety evaluation. J Appl Toxicol. 2013;33(11):1241–50.
Cadet J, Berger M, Buchko GW, Joshi PC, Raoul S, Ravanat J-L. 2, 2-Diamino-4-[(3, 5-di-O-acetyl-2-deoxy-. beta.-D-erythro-pentofuranosyl) amino]-5-(2H)-oxazolone: a novel and predominant radical oxidation product of 3′, 5'-Di-O-acetyl-2′-deoxyguanosine. J Am Chem Soc. 1994;116(16):7403–4.
Cadet J, Douki T, Ravanat JL. Oxidatively generated damage to the guanine moiety of DNA: mechanistic aspects and formation in cells. Acc Chem Res. 2008;41(8):1075–83.
Cadet J, Loft S, Olinski R, Evans MD, Bialkowski K, Richard Wagner J, et al. Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids. Free Radic Res. 2012;46(4):367–81.
Dumont E, Gruber R, Bignon E, Morell C, Moreau Y, Monari A, et al. Probing the reactivity of singlet oxygen with purines. Nucleic Acids Res. 2016;44(1):56–62.
Thapa B, Munk BH, Burrows CJ, Schlegel HB. Computational study of oxidation of guanine by singlet oxygen ((1) Deltag ) and formation of guanine:lysine cross-links. Chemistry. 2017;23(24):5804-.
Ravanat JL, Saint-Pierre C, Di Mascio P, Martinez GR, Medeiros MH, Cadet J. Damage to isolated DNA mediated by singlet oxygen. Helv Chim Acta. 2001;84(12):3702–9.
Acknowledgements
The authors would like to thank Erin Guidry, Eric Kemp, Yash Kapoor, Alexandra Andrews, John Lena, Erika Walsh, and Leonardo Allain for their helpful conversations.
Funding
The funding for all work performed in the preparation of the manuscript came from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA internal budgets. MK-1454 was synthesized by and is the intellectual property of Merck & Co., Inc., Rahway, NJ, USA.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no conflicts of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Brunell, M., Tignor, S., Pierson, E. et al. Photo-Oxidation Mechanisms in Liquid Pharmaceutical Formulations: The Overlooked Role of Singlet Oxygen Presented as a Case Study. Pharm Res 39, 2529–2540 (2022). https://doi.org/10.1007/s11095-022-03374-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-022-03374-z